What we found on the web about Orphan Drug
Orphan drug - Wikipedia, the free encyclopedia
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
Federal Food, Drug, and Cosmetic Act - Wikipedia, the free ...
Orphan Drug Act, PL 97-414 (Jan. 4, 1983) Drug Price Competition and Patent Term Restoration Act of 1984, PL 98-417 (Sept. 24, 1984) Prescription Drug Marketing Act of 1987, PL 100 ...
Orphan Drug Act: Background and Proposed Legislation in the 107th ...
1 For more information see FDA Office of Orphan Products Development Program Overview [http://www.fda. gov/orphan/progovw.htm]. 2 For more information see the NORD website [http ...
Information Centre for Rare Diseases and Orphan Drugs :: Rare Diseases ...
Information Centre for Rare Diseases and Orphan Drugs (ICRDOD) in Bulgaria - the first Eastern European information and educational service, dedicated to all patients, associations ...
orphan drug - FREE orphan drug information | Encyclopedia.com: Facts ...
orphan drug – Facts about orphan drug, pictures, video, and orphan drug information at Encyclopedia.com: a free, credible collection of encyclopedias.
Orphan Drugs - What are Orphan Drugs - All About Orphan Drug Status
Orphan Drug Status is given to certain drugs undergoing development in the pharmaceutical industry. Find out what Orphan Drug Status is and what incentives are available to biotech ...
European Commission - Enterprise and Industry - Pharmaceuticals
Register of designated Orphan Medicinal Products (by number) ... secondary pulmonary hypertension: connective tissue disease pulmonary hypertension, drug ...
orphan drug — Infoplease.com
More on orphan drug from Infoplease: orphan drug: meaning and definitions - orphan drug: Definition and Pronunciation; Suggestions for spelling of encyclopedia/orphan drug - The ...
Orphan Europe : The Orphan Pharmaceutical Company
The Orphan Pharmaceutical Company : Orphan Europe is a pharmaceutical company developing and distributing orphan drugs for the treatment of rare diseases. Whether you are a ...
orphan drug - definition of orphan drug in the Medical dictionary - by ...
drug (drug) 1. a chemical substance that affects the processes of the mind or body. 2. any chemical compound used in the diagnosis, treatment, or prevention of disease or other ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Orphan Drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that would not have otherwise been achieved due to the economics of drug research and development.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Orphan Drug
Reckitt Falls as Detergent, Conditioner Sales Falter (Update1)
Bloomberg
Reckitt, the maker of Lysol and Cillit Bang cleaners, said revenue growth slowed in the third quarter, excluding the Suboxone heroin dependency treatment, sales of which increased 65 percent before the end of its U.S. orphan drug status thi...
Dyax Corp. to Host Third Quarter 2009 Earnings Call and Webcast
Earthtimes
DX-88 has orphan drug designation in the U.S. and E.U., as well as Fast Track designation in the U.S., for this indication. Additionally, DX-88 is being evaluated in two Phase 2 trials for the reduction of blood loss during on-pump ...
Transave Completes Successful Phase II Clinical Program For ARIKACE In ...
Medical News Today
ARIKACE has been granted orphan drug status in the United States by the FDA, and has received an orphan drug designation in Europe by the European Medicines Agency for the treatment of Pseudomonas infections in patients with CF. ARIKACE has...
Dyax Corp. Announces First Quarter 2009 Financial Results
Business Wire via Yahoo! Finance
CAMBRIDGE, Mass.----Dyax Corp. today announced financial results for the first quarter ended March 31, 2009. Dyax will host a webcast and conference call at 10 a.m. this morning to review the financial results and corporate progress for the...
Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
Medical News Today
Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, announced the initiation of a second Phase I human safety trial of...
Data Presented on Oncophage® Cancer Vaccine in Recurrent Glioma at ...
MSN Money
Oncophage received fast track and orphan drug designations from the US Food and Drug Administration (FDA) for both kidney cancer and metastatic melanoma as well as orphan drug designation from the EMEA for kidney cancer. In 2009 ...
Seattle Genetics Reports Product Development Progress and First Quarter 2009 Financial Results
Business Wire via Yahoo! Finance
BOTHELL, Wash.----Seattle Genetics, Inc. today reported financial results for the first quarter ended March 31, 2009. The company also highlighted recent product development progress.
Inhibikase Therapeutics Discusses New Platform For Infectious Disease ...
Medical News Today
The Company's orphan drug program is focused on satisfying an unmet medical need for the treatment of polyomavirus infections. The human polyomaviruses, JC and BK, are responsible for fatal disorders of the brain and kidney, to include prog...
Delcath Systems, Inc. Completes Phase III Study Enrollment
StreetInsider.com
We have achieved several key, strategic milestones, including the successful review of our Phase III safety data, orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma, and the additions of David McDonald as ...
BioMarin Takes Over Huxley
Pharmaceutical Business Review
If approved by the European Commission, amifampridine phosphate will be the first approved treatment for LEMS, thereby conferring orphan drug protection and providing ten years of market exclusivity in Europe. Under the terms of the agreeme...